Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [125I]Radioiodinated DYRK1A Inhibitor. | Molecules | 2025 | 40076215 | PubTator, text mining | PubMed |
| Autism gene variants disrupt enteric neuron migration and cause gastrointestinal dysmotility. | Nat Commun | 2025 | 40050271 | PubTator, text mining | PubMed |
| Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases. | Mol Neurobiol | 2025 | 40044956 | PubTator, text mining | PubMed |
| Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome. | Alzheimers Dement | 2025 | 40042516 | PubTator, text mining | PubMed |
| Hippocampal CaMKII Regulates the Consolidation of Recognition Memory. | Eur J Neurosci | 2025 | 40029612 | PubTator, text mining | PubMed |
| Eriodictyol inhibits the proliferation and inflammatory response in keratinocytes in psoriasis through inactivating DYRK1A-mediated endoplasmic reticulum stress. | J Asian Nat Prod Res | 2025 | 39987551 | PubTator, text mining | PubMed |
| Complex Multifocal Dystonia, Intellectual Disability, and Stereotypies Due to a Novel DYRK1A Variant. | Mov Disord Clin Pract | 2025 | 39969062 | PubTator, text mining | PubMed |
| From Dyrk1A inhibitors to a novel class of antiviral agents: Targeting Enterovirus EV-A71 with 2-aryl-substituted thiophene scaffolds. | Eur J Med Chem | 2025 | 39947051 | PubTator, text mining | PubMed |
| Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation. | Immunohorizons | 2025 | 39846842 | PubTator, text mining | PubMed |
| Adaptive functioning in children and young adults with monogenic neurodevelopmental disorders. | Dev Med Child Neurol | 2025 | 39846212 | PubTator, text mining | PubMed |
| How a gene fuels ear infections. | Elife | 2025 | 39840732 | PubTator, text mining | PubMed |
| Re-evaluation of the Bahariya Formation carcharodontosaurid (Dinosauria: Theropoda) and its implications for allosauroid phylogeny. | PLoS One | 2025 | 39808629 | PubTator, text mining | PubMed |
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. | Clin Exp Rheumatol | 2025 | 39808288 | PubTator, text mining | PubMed |
| DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma. | Dev Cell | 2025 | 39798576 | PubTator, text mining | PubMed |
| Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C. | Sci Rep | 2025 | 39774736 | PubTator, text mining | PubMed |
| Evaluation of Safety and Efficacy of a Single Lorecivivint Injection in Patients with Knee Osteoarthritis: A Multicenter, Observational Extension Trial. | Rheumatol Ther | 2025 | 39755925 | PubTator, text mining | PubMed |
| Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment. | Protein Pept Lett | 2025 | 39716791 | PubTator, text mining | PubMed |
| Lithium normalizes ASD-related neuronal, synaptic, and behavioral phenotypes in DYRK1A-knockin mice. | Mol Psychiatry | 2025 | 39633007 | PubTator, text mining | PubMed |
| Two remarkable cases of haploinsufficiency found in the DYRK1A gene. | Acta Neurol Belg | 2025 | 39572511 | PubTator, text mining | PubMed |
| Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. | Rheumatology (Oxford) | 2025 | 39495154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=9